Grifols S.A.

Research activity is centered on severe alpha-1 antitrypsin deficiency (AATD), with attention to the clinical management of this inherited protein deficiency disorder and its impact on long-term health.

• Severe AATD
• Inherited respiratory and hepatic disease
• Protein replacement therapy

The sponsor’s funded research in this area reflects interest in treatment approaches for patients living with advanced deficiency-related disease.